Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitrous-oxide reductase (N2OR) is a **bacterial metalloenzyme** that catalyzes the final step of denitrification, reducing the potent greenhouse gas **nitrous oxide (N₂O) to inert dinitrogen (N₂)**[1][2][3][4][5]. It is a homodimeric multicopper oxidoreductase located in the periplasm of denitrifying bacteria, with each monomer containing two specialized copper centers: **CuA** (electron transfer site) and **CuZ** (catalytic site; a distinct tetranuclear copper-sulfide cluster)[2][4][5]. Head-to-tail dimerization positions these centers from opposing monomers in optimal proximity for cooperative catalysis[2][4][5]. N2OR is essential for environmental nitrogen cycling and mitigation of greenhouse gas emissions, as it is presently the only known enzyme capable of deleting N₂O from the biosphere[3][4][5]. Its activity is regulated by the *nosZ* gene, and its dysfunction or inhibition (by compounds including acetylene, azide, and cyanide) results in incomplete denitrification and heightened N₂O emissions[1][2][3]. N2OR does not have direct clinical applications or recognized roles in human disease but is a crucial environmental target in efforts to reduce atmospheric N₂O and its associated climate impacts.
Inhibitors: Blockage of copper centers and/or active/catalytic sites, preventing electron transfer and subsequent reduction of N₂O to N₂[1]. - Enzymatic catalysis: 2H⁺/2e⁻-dependent reduction of N₂O to N₂ (biotransformation)[2][5].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrous-oxide reductase (N2OR).